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Conclusion	
Significance	of	Pathophysiology	of	Afib	
•  The	heart’s	natural	pacemaker	is	the	sinus	node	(SN).	SN	makes	electrical	
signals,	which	cause	the	heart	to	contract	and	pump	blood	(Heart.org,	2018).	
Unlike	other	cells,	cardiac	cells	are	capable	of	self-sEmulaEon	(Cutugno,	2015).		
•  In	AFib,	mulEple	atrial	cells	self-sEmulate,	behaving	as	individual	pacemakers	
and	compeEng	with	the	SN	for	control	of	cardiac	acEvity.	Afib	is	a	random	
electrical	acEvity,	where	mulEple	atrial	cells	self-sEmulate,	behaving	as	
individual	pacemakers	and	compete	with	the	SN	for	control	of	cardiac	acEvity	
(Cutungo,	2015).	
•  Normal	atrial	contracEons	are	replaced	by	rapid	quivering	movements	and	the	
atria	stop	contracEng	effecEvely	(Cutungo,	2015).	When	the	atria	quiver,	blood	
pools	in	the	atria.	Pooling	of	blood	in	atria	can	cause	blood	clots	(Heart.org,	
2018).	
•  Afib	predisposes	a	paEent	to	develop	blood	clots	(Heart.org,	2018).	Because	Afib	
causes	a	lack	of	coordinated	atrial	contracEons,	it	can	result	in	one	of	the	most	
common	complicaEons	of	atrial	fibrillaEon,	thrombi	formaEon	(Cutugno,	2015).	
•  The	formaEon	of	thrombi	on	the	atrial	walls	and	within	the	leS	atrial	appendage	
(LAA)	occurs	when	ineffecEve	emptying	allows	blood	to	pool	in	these	chambers.	
Commonly	referred	to	as	mural	thrombi,	these	clots	can	dislodge	and	cause	
strokes	and	other	systemic	thrombi	(Cutugno,	2015).		
•  	Blood	clots	can	then	dislodge	and	travel	to	the	brain	to	cause	a	stroke	(Spivak,	
2015).	Numerous	large,	randomized	studies	have	shown	that	anEcoagulaEon	
reduces	the	risk	of	stroke	by	about	two-thirds	in	paEents	with	Afib	(Hagerty	and	
Rich,	2017).	
•  PaEents	with	Afib	are	oSen	prescribed	anEcoagulaEon	to	decrease	risk	of	blood	
clots	(Spivak	2015).	PaEents	at	risk	for	bleeding	may	be	too	high	risk	to	be	on	
anEcoagulaEon.	Other	opEons	need	assessed	for	high	risk	bleeding	and	high	
CHA2DS2-Vasc	score.	
•  Aging	is	an	unavoidable	human	a[ribute	which	happens	to	everyone,	
some	individuals	age	be[er	than	others.	With	the	aging	process,	there	
comes	increased	health	risks	and	a	decline	in	one’s	health,	parEcularly	
increased	risk	of	heart	disease	and	irregular	heart	rhythms	(Heart.org,	
2018).		Included	in	health	risks	associated	with	advanced	age	is	the	
evidence	in	clinical	pracEce	that	the	elderly	are	at	increased	risk	for	
falls	(Shah,	2013).		   	
•  Atrial	FibrillaEon	(AFib)	is	the	most	common	cardiac	arrhythmia	and	its	
prevalence	increases	with	age	(Shah,	2013).	Given	the	aging	of	the	U.S.	
populaEon,	the	incidence	of	Afib	is	expected	to	more	than	double	over	
the	next	50	years	(Cutugno,	2015).	
•  Afib	incidence	is	25%	in	individuals	by	age	80	affecEng	one	in	every	10	
individuals	over	age	80	(Spivak,	2015).	Incidence	doubles	with	each	
decade	of	life	aSer	age	50	(Shah,	2013).).	
•  Risk	for	stroke	is	five	Emes	higher	in	those	with	Afib	and	advanced	age,	
and	accounts	for	25%	of	acute	ischemic	strokes	(Alkhouli	et	al,	
2018).The	risk	of	stroke	can	be	reduced	if	the	paEent	meets	criteria	to	
be	on	oral	anEcoagulaEon	(AC)	(Heart.org,	2018).	
	
•  CHA2DS2-VASc	(Figure	3)	is	a	scoring	system	uElized	to	assess	the	
need	for	AC	to	prevent	stroke	from	Afib.	AC	is	recommended	for	a	
CHA2DS2-VASc	score	of	2	or	more	(Hagerty	and	Rich,	2017).	Once	it	
has	been	determined	a	paEent	should	be	treated	with	AC,	then	
consideraEon	of	clot	formaEon	or	bleeding	risks	should	be	weighed.	
Not	every	paEent	is	a	candidate	for	anEcoagulaEon	(Spivak,	2015).		
•  HAS-BLED	(Figure	1)		is	a	scoring	system	used	for	assessing	bleeding	
risks	in	paEents	(Hagerty	and	Rich,	2017).	The	HAS-Bled	score	has	been	
used	more	widely	in	recent	years	(Hagerty	and	Rich,	2017).	
•  A	clinician	must	heavily	weigh	the	opEons	of	treatment	for	the	paEent	
with	AF	who	is	at	risk	for	falls	(Cutugno,	2015).	Other	opEons	should	
be	considered	for	paEents	that	are	unable	to	tolerate	AC.	Because	
thrombi	typically	occur	in	the	leS	atrial	appendage,	leS	atrial	
appendage	closer	(LAAC)	has	emerged	as	an	alternaEve	in	select	
paEents		(Reddy	et	al,	2017).	
•  Through	educaEon	clinicians	can	provide	paEents	and	family	members	
the	knowledge	of	signs	and	symptoms,	risk	factors	and	the	appropriate	
Eme	for	paEents	to	consider	treatment	with	AC	or	alternaEves	such	as	
LAAC	if	appropriate.		
•  Afib	was	the	chosen	topic	due	to	the	prevalence	of	this	parEcular	
arrhythmia	and	the	potenEal	adverse	effects	with	increased	risk	of	
stroke.	It	is	important	for	the	nurse	pracEEoner	to	recognize	when	
paEents	present	with	Afib	and	create	the	appropriate	plan	of	care	to	
reduce	risk	of	stroke,	while	at	the	same	Eme	reducing	adverse	effects	
from	AC.	
Introduc(on	
Signs	and	Symptoms	
•  Irregular	and	rapid	heartbeat	
•  Heart	palpitations	or	rapid	thumping		inside	the	chest	
•  Dizziness,	sweating	and	chest	pain	or	pressure	
•  Shortness	of	breath	
•  Tiring	more	easily		
•  Fainting	(syncope)	
•  Can	be	asymptomatic	
	 Risk	Factors	
CHA2DS	2-VASc	Score	and	Risk	Criteria	
	
Pathophysiology	
•  Educate	paEents	and	family	
members	on	the	risk	factors	and	
sign	and	symptoms	of	Afib.	
•  Recognize	paEents	at	increased	risk	
for	stroke	from	Afib	through	use	of	
the	CHA2DS-2-Vasc	score	for	
indicaEons	of	AC.	
•  Recognize	paEents	at	risk	for	
bleeding	(e.g.	paEents	at	risk	for	
falls)	with	use	of	the	HAS-BLED	
score.	
•  Know	alternaEve	opEons	for	those	
at	risk	of	falls	or	bleeding	such	as	a	
LAAC	(e.g.	Watchman	device).	
•  Educate	paEents	and	family	
members	to	develop	a	collaboraEve	
healthcare	plan.	
•  Current	guidelines	primarily	support	
the	use	of	AC	in	paEents	to	prevent	
thromboembolism	and	control	
symptoms	in	the	high	risk	paEent	
with	Afib.	Guidelines	also	stress	the	
importance	of	paEent	adherence	to	
treatment	plans	in	achieving	
improved	outcomes.	There	is	
evidence	that	nursing	intervenEons	
in	paEent	educaEon	and	in	care	
coordinaEon,	can		improve	paEent	
outcomes	and	decrease	costs	
(Cutugno,	2015).	
•  In	considering	the	paEent	
presented,	the	79	year	old	female	
with	HTN	has	a	CHA2DS	2-VASc	
score	of	4,	increasing	her	risk	of	
stroke.	Because	she	has	a	score	of	>	
2,	the	paEent	is	a	candidate	for	AC.	
The	paEent	admits	to	falling.	This	
places	her	at	an	increase	risk	of	
bleeding	per	the	HAS-BLED	score,	if	
AC	is	iniEated.	A	plan	of	care	should	
be	developed	with	the	paEent’s	
family	weighing	her	risk	of	stroke	
versus	risk	of	bleeding	with	
providing	potenEal	alternaEves	with	
a	LAAC	device.	
•  Prior	heart	a[ack	or	heart	disease	
•  High	blood	pressure	
•  Diabetes	
•  Sleep	Apnea	
•  Excessive	alcohol,	smoking,	stress	
CongesEve	heart	failure	 1	point	
Hypertension	 1	point	
Age	≥75	years		 2	points	
Diabetes	mellitus	 1	point	
Stroke/TIA/Thromboembolic	event	 2	points	
Vascular	disease	(MI,	PAS,	or	aorEc	plaque)	 1	point	
Age	65	to	74	years	 1	point	
Sex	category	(i.e.	female	sex)	 1	point	
Figure	3.	Scoring	system	to	determine	risk	of																										
clot	forma(on	with	Afib	(Emedicine,	2018)	
Figure	2.	Representa(on	of	signs	and	symptoms	of	Afib	
(heart.org,	2018).	
Figure	4.	Normal	heart	compared	to	heart	in	Afib	(Holdright,	2010).	
•  Balancing	the	risk	of	stroke	
against	the	risk	of	bleeding	
related	to	falls	Is	a	commonly	
encountered	conundrum	in	
older	paEents	with	Afib	(Hagerty	
and	Rich,	2017).	
•  People	with	untreated	or	
undertreated	atrial	fibrillaEon	
are	at	high	risk	for	
thromboembolism;	to	lower	that	
risk,	anEcoagulaEon	therapy	is	
recommended.	This	increases	
the	risk	of	bleeding	
complicaEons	and	a	potenEally	
devastaEng	outcome.	Risk	
straEficaEon	for	both	stroke	and	
bleeding	can	help	guide	
informed	decision	making	
(Cutugno,	2015).	
•  CHA2DS-VASc	Score	is	a	
convenient	tool	for	straEfying	
risk	in	paEents	with	Afib	and	
determining	the	need	for	AC	
(Spivak,	2015).		
•  If	it	is	determined	that	paEents	
are	high	risk	for	bleeding,	such	
as	the	elderly	at	risk	for	falls,	
then	an	alternaEve	form	of	
treatment	may	be	chosen	if	
desired	aSer	proper	educaEon.	
The	LAAC	is	an	emerging	device	
that	will	block	off	the	leS	atrial	
appendage	and	decrease	the	
risk	of	clot	formaEon	from	Afib	
(Reddy	et	al,	2018).	
•  Because	there	is	such	a	high	risk	
of	developing	a	blood	clot	in	the	
paEent	with	AF,	anEcoagulaEon	
is	the	most	common	course	of	
treatment.	When	the	risk	of	
bleeding	outweighs	the	benefit	
of	oral	anEcoagulaEon,	the	
nurse	pracEEoner	will	need	to	
look	at	alternaEve	treatment,	
for	leS	atrial	appendage	closure	
(Reddy	et	al,	2018).		
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•  79	year	old	female	with	history	of	hypertension	(HTN)	
presents	to	the	clinic	staEng	she	has	been	more	Ered	
than	usual.	PaEent	states	has	felt	palpitaEons	in	her	
chest	and	feels	as	though	her	heart	is	racing.	
•  Upon	assessment	and	auscultaEon	of	the	paEent’s	
heart,	an	irregular	rhythm	with	a	rate	in	the	120s	is	
revealed.	
•  Electrocardiogram	confirms	the	paEent	is	in	Atrial	
FibrillaEon.	
•  PaEent	informs	the	nurse	pracEEoner	that	she	has	been	
under	a	lot	of	stress	with	caring	for	her	ill	husband.	
•  PaEent	also	admits	she	has	fallen	a	couple	of	Emes	but	
states	it	is	because	she	is	so	Ered	all	the	Eme.	
HAS-BLED	 Points	 HAS-BLED	 Points	
Hypertension	 1	 Abnormal	renal	funcEon	 1	
Abnormal	liver	funcEon	 1	 Stroke	 1	
Bleeding	history	 1	 Labile	INR	 1	
Elderly	(age	>	65)	 1	 Drugs	 1	
Alcohol	 1	
Figure	1.	Scoring	system	to	determine	risk	of	bleeding	
(Hagerty	and	Rich,	2017)	
Picture	retrieved	from	Heart.org,	2018.	
